IMMUNITYBIO, INC. Interest and Other Income
IMMUNITYBIO, INC. (IBRX) reported Interest and Other Income of $736.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-05-07
- IMMUNITYBIO, INC. interest and other income for the quarter ending 2026-03-31 was $736.00K, a 41.54% increase year-over-year.
- IMMUNITYBIO, INC. interest and other income for the quarter ending 2025-12-31 was $579.00K, a 24.71% decline year-over-year.
- IMMUNITYBIO, INC. interest and other income for the quarter ending 2025-09-30 was $772.00K, a 21.00% increase year-over-year.
- IMMUNITYBIO, INC. interest and other income for the quarter ending 2025-06-30 was $818.00K, a 1.80% decline year-over-year.
- IMMUNITYBIO, INC. interest and other income for fiscal 2025 was $2.69M, a 12.04% increase from fiscal 2024.
- IMMUNITYBIO, INC. interest and other income for fiscal 2024 was $2.40M, a 178.10% increase from fiscal 2023.
- IMMUNITYBIO, INC. interest and other income for fiscal 2023 was $863.00K, a 68.13% decline from fiscal 2022.
- IMMUNITYBIO, INC. interest and other income for fiscal 2022 was $2.71M, a 223.92% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-03-31 | $736.00K 10-Q · filed 2026-05-07 | $1.31M derived: sum of 2 quarters · filed 2026-05-07 | $2.09M derived: sum of 3 quarters · filed 2026-05-07 | $2.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.35M derived: sum of 2 quarters · filed 2026-02-23 | $2.17M derived: sum of 3 quarters · filed 2026-02-23 | $2.69M 10-K · filed 2026-02-23 |
| 2025-09-30 | $772.00K 10-Q · filed 2025-11-05 | $1.59M derived: sum of 2 quarters · filed 2025-11-05 | $2.11M 10-Q · filed 2025-11-05 | $2.88M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | $818.00K 10-Q · filed 2025-08-05 | $1.34M 10-Q · filed 2025-08-05 | $2.11M derived: sum of 3 quarters · filed 2026-05-07 | $2.75M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | $520.00K 10-Q · filed 2026-05-07 | $1.29M derived: sum of 2 quarters · filed 2026-05-07 | $1.93M derived: sum of 3 quarters · filed 2026-05-07 | $2.76M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $769.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.41M derived: sum of 2 quarters · filed 2026-02-23 | $2.24M derived: sum of 3 quarters · filed 2026-02-23 | $2.40M 10-K · filed 2026-02-23 |
| 2024-09-30 | $638.00K 10-Q · filed 2025-11-05 | $1.47M derived: sum of 2 quarters · filed 2025-11-05 | $1.63M 10-Q · filed 2025-11-05 | $1.01M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $833.00K 10-Q · filed 2025-08-05 | $993.00K 10-Q · filed 2025-08-05 | $370.00K derived: sum of 3 quarters · filed 2026-02-23 | $980.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $160.00K 10-Q · filed 2025-05-12 | -$463.00K derived: sum of 2 quarters · filed 2026-02-23 | $147.00K derived: sum of 3 quarters · filed 2026-02-23 | $739.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$623.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$13.00K derived: sum of 2 quarters · filed 2026-02-23 | $579.00K derived: sum of 3 quarters · filed 2026-02-23 | $863.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $610.00K 10-Q · filed 2024-11-12 | $1.20M derived: sum of 2 quarters · filed 2024-11-12 | $1.49M 10-Q · filed 2024-11-12 | $2.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $592.00K 10-Q · filed 2024-08-12 | $876.00K 10-Q · filed 2024-08-12 | $1.39M derived: sum of 3 quarters · filed 2025-03-03 | $1.64M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $284.00K 10-Q · filed 2024-05-09 | $799.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.05M derived: sum of 3 quarters · filed 2025-03-03 | $1.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $768.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.41M derived: sum of 3 quarters · filed 2025-03-03 | $2.71M 10-K · filed 2025-03-03 |
| 2022-09-30 | $253.00K 10-Q · filed 2023-11-09 | $897.00K derived: sum of 2 quarters · filed 2023-11-09 | $2.19M 10-Q · filed 2023-11-09 | $2.48M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $644.00K 10-Q · filed 2023-08-08 | $1.94M 10-Q · filed 2023-08-08 | $2.22M derived: sum of 3 quarters · filed 2024-03-19 | $2.33M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $1.30M 10-Q · filed 2023-05-11 | $1.58M derived: sum of 2 quarters · filed 2024-03-19 | $1.68M derived: sum of 3 quarters · filed 2024-03-19 | $1.79M derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $385.00K derived: sum of 2 quarters · filed 2024-03-19 | $497.00K derived: sum of 3 quarters · filed 2024-03-19 | $836.00K 10-K · filed 2024-03-19 |
| 2021-09-30 | $101.00K 10-Q · filed 2022-11-09 | $213.00K derived: sum of 2 quarters · filed 2022-11-09 | $552.00K 10-Q · filed 2022-11-09 | $1.08M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $112.00K 10-Q · filed 2022-08-08 | $451.00K 10-Q · filed 2022-08-08 | $977.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.51M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $339.00K 10-Q · filed 2022-05-10 | $865.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.40M derived: sum of 3 quarters · filed 2023-03-01 | $1.74M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.06M derived: sum of 2 quarters · filed 2023-03-01 | $1.40M derived: sum of 3 quarters · filed 2023-03-01 | $1.73M 10-K · filed 2023-03-01 |
| 2020-09-30 | $536.00K 10-Q · filed 2021-11-12 | $877.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.20M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $341.00K 10-Q · filed 2021-08-12 | $663.00K 10-Q · filed 2021-08-12 | ||
| 2019-12-31 | $2.76M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |